14.335 USD
-0.02 (-0.17%)
INMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. INMD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes INMD very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year INMD was profitable.
INMD had a positive operating cash flow in the past year.
INMD had positive earnings in each of the past 5 years.
INMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
INMD has a better Return On Assets (20.39%) than 99.47% of its industry peers.
INMD has a Return On Equity of 22.93%. This is amongst the best in the industry. INMD outperforms 95.72% of its industry peers.
With an excellent Return On Invested Capital value of 11.95%, INMD belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for INMD is significantly above the industry average of 8.81%.
The 3 year average ROIC (22.89%) for INMD is well above the current ROIC(11.95%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.39% | ||
| ROE | 22.93% | ||
| ROIC | 11.95% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
1.3 Margins
INMD's Profit Margin of 41.10% is amongst the best of the industry. INMD outperforms 98.93% of its industry peers.
INMD's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 23.98%, INMD belongs to the best of the industry, outperforming 94.65% of the companies in the same industry.
In the last couple of years the Operating Margin of INMD has declined.
INMD has a Gross Margin of 78.82%. This is amongst the best in the industry. INMD outperforms 91.44% of its industry peers.
INMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.98% | ||
| PM (TTM) | 41.1% | ||
| GM | 78.82% |
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INMD is creating value.
The number of shares outstanding for INMD has been reduced compared to 1 year ago.
The number of shares outstanding for INMD has been increased compared to 5 years ago.
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.39
WACC8.61%
2.3 Liquidity
A Current Ratio of 9.75 indicates that INMD has no problem at all paying its short term obligations.
With an excellent Current ratio value of 9.75, INMD belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
INMD has a Quick Ratio of 8.71. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 8.71, INMD belongs to the top of the industry, outperforming 91.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.75 | ||
| Quick Ratio | 8.71 |
3. Growth
3.1 Past
INMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.67%.
INMD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.97% yearly.
Looking at the last year, INMD shows a very negative growth in Revenue. The Revenue has decreased by -13.98% in the last year.
The Revenue has been growing by 20.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-45.71%
Revenue 1Y (TTM)-13.98%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
3.2 Future
Based on estimates for the next years, INMD will show a small growth in Earnings Per Share. The EPS will grow by 0.88% on average per year.
The Revenue is expected to decrease by -0.07% on average over the next years.
EPS Next Y-9.69%
EPS Next 2Y-2.43%
EPS Next 3Y0.88%
EPS Next 5YN/A
Revenue Next Year-8.35%
Revenue Next 2Y-2.49%
Revenue Next 3Y-0.07%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.07 indicates a reasonable valuation of INMD.
Based on the Price/Earnings ratio, INMD is valued cheaper than 94.65% of the companies in the same industry.
INMD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.34.
Based on the Price/Forward Earnings ratio of 8.46, the valuation of INMD can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 95.72% of the companies listed in the same industry.
INMD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.56.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.07 | ||
| Fwd PE | 8.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 98.40% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INMD is valued cheaply inside the industry as 96.79% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.55 | ||
| EV/EBITDA | 2.88 |
4.3 Compensation for Growth
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.4
EPS Next 2Y-2.43%
EPS Next 3Y0.88%
5. Dividend
5.1 Amount
INMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:INMD (12/9/2025, 10:31:59 AM)
14.335
-0.02 (-0.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners58.99%
Inst Owner Change2.1%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap906.12M
Revenue(TTM)364.49M
Net Income(TTM)149.81M
Analysts74.29
Price Target17.14 (19.57%)
Short Float %5.51%
Short Ratio4.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.86%
Min EPS beat(2)5.11%
Max EPS beat(2)10.61%
EPS beat(4)2
Avg EPS beat(4)-4.56%
Min EPS beat(4)-20.27%
Max EPS beat(4)10.61%
EPS beat(8)4
Avg EPS beat(8)-5.17%
EPS beat(12)7
Avg EPS beat(12)-1.22%
EPS beat(16)11
Avg EPS beat(16)1.65%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-2.87%
Max Revenue beat(2)3.38%
Revenue beat(4)1
Avg Revenue beat(4)-2.96%
Min Revenue beat(4)-9.96%
Max Revenue beat(4)3.38%
Revenue beat(8)2
Avg Revenue beat(8)-5.49%
Revenue beat(12)5
Avg Revenue beat(12)-3.96%
Revenue beat(16)9
Avg Revenue beat(16)-1.5%
PT rev (1m)0.9%
PT rev (3m)3.38%
EPS NQ rev (1m)-1.85%
EPS NQ rev (3m)-8.77%
EPS NY rev (1m)-0.21%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.07 | ||
| Fwd PE | 8.46 | ||
| P/S | 2.49 | ||
| P/FCF | 9.55 | ||
| P/OCF | 9.48 | ||
| P/B | 1.39 | ||
| P/tB | 1.39 | ||
| EV/EBITDA | 2.88 |
EPS(TTM)1.58
EY11.02%
EPS(NY)1.69
Fwd EY11.82%
FCF(TTM)1.5
FCFY10.47%
OCF(TTM)1.51
OCFY10.55%
SpS5.77
BVpS10.34
TBVpS10.34
PEG (NY)N/A
PEG (5Y)0.4
Graham Number19.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.39% | ||
| ROE | 22.93% | ||
| ROCE | 13.12% | ||
| ROIC | 11.95% | ||
| ROICexc | 59.43% | ||
| ROICexgc | 59.43% | ||
| OM | 23.98% | ||
| PM (TTM) | 41.1% | ||
| GM | 78.82% | ||
| FCFM | 26.04% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
ROICexc(3y)532.49%
ROICexc(5y)5023.19%
ROICexgc(3y)532.49%
ROICexgc(5y)5023.19%
ROCE(3y)25.13%
ROCE(5y)28.51%
ROICexgc growth 3Y-60.68%
ROICexgc growth 5YN/A
ROICexc growth 3Y-60.68%
ROICexc growth 5YN/A
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
F-Score5
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 86.64% | ||
| Cap/Sales | 0.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 108.41% | ||
| Profit Quality | 63.36% | ||
| Current Ratio | 9.75 | ||
| Quick Ratio | 8.71 | ||
| Altman-Z | N/A |
F-Score5
WACC8.61%
ROIC/WACC1.39
Cap/Depr(3y)144.54%
Cap/Depr(5y)147.73%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.23%
Profit Quality(3y)91.09%
Profit Quality(5y)96.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-45.71%
EPS Next Y-9.69%
EPS Next 2Y-2.43%
EPS Next 3Y0.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.98%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
Revenue Next Year-8.35%
Revenue Next 2Y-2.49%
Revenue Next 3Y-0.07%
Revenue Next 5YN/A
EBIT growth 1Y-35.42%
EBIT growth 3Y-12.42%
EBIT growth 5Y13.55%
EBIT Next Year-38.82%
EBIT Next 3Y-11.56%
EBIT Next 5YN/A
FCF growth 1Y-44.72%
FCF growth 3Y-8.8%
FCF growth 5Y16.5%
OCF growth 1Y-44.69%
OCF growth 3Y-8.8%
OCF growth 5Y16.36%
INMODE LTD / INMD FAQ
Can you provide the ChartMill fundamental rating for INMODE LTD?
ChartMill assigns a fundamental rating of 7 / 10 to INMD.
What is the valuation status for INMD stock?
ChartMill assigns a valuation rating of 8 / 10 to INMODE LTD (INMD). This can be considered as Undervalued.
How profitable is INMODE LTD (INMD) stock?
INMODE LTD (INMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of INMODE LTD (INMD) stock?
The Price/Earnings (PE) ratio for INMODE LTD (INMD) is 9.07 and the Price/Book (PB) ratio is 1.39.
What is the financial health of INMODE LTD (INMD) stock?
The financial health rating of INMODE LTD (INMD) is 8 / 10.